Press Releases
We’re Delivering the Promise of Healthier Lives.
CURE PHARMACEUTICAL
Press Releases
We specialize in optimal formulations to achieve targeted release and exposure of medications.
Nicole Kidman, Sera Labs Strategic Business Partner/Global Brand Ambassador and Nancy Duitch, Sera Labs Founder/CEO Headline Collision 2021
LOS ANGELES--(BUSINESS WIRE)--Sera Labs, a subsidiary of CURE Pharmaceutical Holding Corp. (OTC: CURR), announced today that Academy Award, Golden Globe and Emmy Award-winning actor/producer/entrepreneur Nicole Kidman and Sera Labs CEO/CURE Pharmaceutical Chief...
CURE Pharmaceutical Reports Increase in Revenue to $7.7 Million on a Pro Forma Basis in 2020
Fiscal Year 2020 Highlights: Generated dramatic growth in total and pro forma revenue Released positive clinical data on its patented drug delivery technology and received new certifications at its research facility Acquired and expanded consumer wellness subsidiary...
CURE Pharmaceutical Launches Psychedelic Oral Film Program Targeting the Treatment of Mental Health Disorders
OXNARD, Calif. - CURE Pharmaceutical Holding Corp. ("CURE" or the "Company") (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched a new initiative for the clinical development of psychedelic compounds...
CURE Pharmaceutical Announces Addition of Two New Clinical Development Programs Targeting Anti-Seizure and Antiviral Applications
OXNARD, Calif. - CURE Pharmaceutical Holding Corp. ("CURE" or the "Company") (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched two new clinical development programs and added new corresponding...
CURE Pharmaceutical’s Subsidiary Sera Labs Launches National Television, Radio & Digital Advertising Campaign for Nutri-Strips Sleep A.S.A.P.
Sleep A.S.A.P. provides proof of concept and monetization for CURE's patented oral thin-film technology LOS ANGELES & OXNARD, Calif. - CURE Pharmaceutical Holding Corp. ("CURE" or the "Company") (OTC: CURR), a technology focused, vertically integrated drug...
CURE Pharmaceutical Announces the Initiation of Clinical Trials for Erectile Dysfunction Product CUREfilm Blue™
OXNARD, Calif. - CURE Pharmaceutical Holding Corp. ("CURE" or the "Company") (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced this week's start of...
CURE Pharmaceutical Announces Promotions and Additions to Board of Directors
OXNARD, Calif. - CURE Pharmaceutical Holdings ("CURE" or the "Company") (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today updates and additions to its Board of Directors. After...
Sera Labs Unveils ImmunD₃™ an Important New Offering to the Nutri-Strips™ Product Line; Launches New Digital E-commerce Website to Amplify Consumer Awareness
Sera Labs Pioneers the Delivery of Next Generation Immune Support in the Continued Battle Against the COVID-19 Pandemic LOS ANGELES & OXNARD, Calif. - According to the National Institute of Health (NIH) more than 50 percent of people worldwide have Vitamin D...
Sera Labs, Inc. Wins Prestigious Retail Excellence Award
Health, Wellness, CBD and plant-based anti-aging skincare powerhouse, Sera Labs wins Drug Store News' annual Natural Products Award LOS ANGELES & OXNARD, Calif. - The retailers have spoken! Sera Labs, Inc., the wholly owned subsidiary of CURE Pharmaceutical...
CURE Pharmaceutical to Present at 2021 NobleCon17 on Tuesday, January 19 at 3pm EST/12pm PST
OXNARD, Calif. - CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company's Chief Executive Officer...
CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference
OXNARD, Calif. - CURE Pharmaceutical Holding Corp ("CURE" or the "Company") (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company's...
CURE Pharmaceutical Receives FDA Approval for its IND Application for Erectile Dysfunction Product CUREfilm Blue™
OXNARD, Calif. - CURE Pharmaceutical Holding Corp. ("CURE" or the "Company") (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the U.S....
CURE Pharmaceutical to Present at LD Micro on December 15, Schedules Investor Video Webcast for December 17
OXNARD, Calif. - CURE Pharmaceutical Holdings ("CURE" or the "Company") (OTCQB: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, today announced that management will present on the company at the LD...
Nicole Kidman Partners With SeraLabs, a CURE Pharmaceutical Company, as a Strategic Business Partner and Global Brand Ambassador
SeraLabs is a Leading CBD Health, Wellness & Beauty Company Kidman's partnership is exclusively with SeraLabs Topicals LOS ANGELES & OXNARD, Calif. - CURE Pharmaceutical Holdings (OTCQB: CURR) wholly owned subsidiary, The SeraLabs, Inc., has enlisted Oscar,...
CURE Pharmaceutical Issues Letter to Shareholders
OXNARD, Calif. - CURE Pharmaceutical Holdings ("CURE" or the "Company") (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today that it has issued a letter to its shareholders...
CURE Pharmaceutical Closes $10 Million Financing
- Funds will support the branding & product launch of Cure's consumer products by newly acquired Sera Labs and the advancement of CURE's clinical pharmaceutical pipeline - OXNARD, Calif. - CURE Pharmaceutical Holdings (OTC: CURR), a developer and manufacturer of...
CURE Pharmaceutical's® Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a Revolutionary Oral Thin Film Strip Technology
SeraLabs Challenges the Status Quo of the Health & Wellness Sector with Nutri-Strips for commercialization and monetization with the launch of first product, Sleep A.S.A.P.CURE Pharmaceutical Holding (OTCQB: CURR) wholly owned subsidiary Sera Labs is challenging...
CURE Pharmaceutical Completes $20 Million Acquisition of Sera Labs, a Leading Health, Wellness and Beauty Brand Marketing and Multi-Channel Distribution Platform Company
- Acquisition to Support Cash Flow Positive Goal in ~18 Months - OXNARD, Calif. - CURE Pharmaceutical Holdings (OTC: CURR) today announced its definitive agreement to acquire Sera Labs, Inc. The closing is anticipated to occur in early October. As previously...
CURE Pharmaceutical to Present at Two Virtual Events in September
- CURE will present at the LD 500 Virtual Conference, September 4 at 8:20 am PDT - - CURE CEO will be a panelist at the 4@4 Forum on September 10 @4pm PDT - OXNARD, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug...
CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction
CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel
Significantly higher serum concentration and absorption showcases CUREform
CURE Pharmaceutical Receives NSF
OXNARD, Calif. -- July 8, 2020 -- CURE Pharmaceutical, (OTC: CURR), an innovative drug delivery and development company, today announced that its 25,000 square foot manufacturing facility has earned NSF International, cGMP certification for the manufacture of dietary...
CURE Pharmaceutical Appoints Chief Business Officer
CURE Pharmaceutical Announces Exercise of Warrants for Cash Proceeds of Approximately $1.4 Million and Completes Earn Out Related to 2019 Acquisition
OXNARD, Calif. June 9, 2020
CURE Pharmaceutical Expands to Mexico in Collaboration with Factoria Bogar Subsidiary
CURE extends vitamin D, sleep and combination CBD products distribution throughout Mexico OXNARD, Calif., June 03, 2020 (GLOBE NEWSWIRE) --